FDA interprets the FDCA not to permit compounding for “office use” under Section 503A;

Food and Drug Law Alert

https://www.akingump.com/.../FDA-Iss...

Akin Gump Strauss Hauer & Feld

16 hours ago - FDA interprets the FDCA not to permit compounding for “office use” under Section 503A; compounding pharmacies must receive a valid prescription for an individually identified patient before distributing compounded drugs to a hospital, clinic or other health care facility.